These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 37850
1. [Relationship between perazine serum concentration and clinical results in long-term treated schizophrenic outpatients (author's transl)]. Pietzcker A, Müller-Oerlinghausen B, Schley J, Chaskel H, Poppenberg A, Urban R. Arzneimittelforschung; 1978; 28(8):1302-3. PubMed ID: 37850 [Abstract] [Full Text] [Related]
3. Outcome and risks of ultra-long-term treatment with an oral neuroleptic drug. Relationship between perazine serum levels and clinical variables in schizophrenic outpatients. Pietzcker A, Poppenberg A, Schley J, Müller-Oerlinghausen B. Arch Psychiatr Nervenkr (1970); 1981; 229(4):315-29. PubMed ID: 6111989 [Abstract] [Full Text] [Related]
8. Predictors of neuroleptic treatment response in acute schizophrenia: results of a treatment study with perazine. Gaebel W, Pietzcker A, Ulrich G, Schley J, Müller-Oerlinghausen B. Pharmacopsychiatry; 1988 Nov; 21(6):384-6. PubMed ID: 2907645 [No Abstract] [Full Text] [Related]
9. [Changes in drug elimination under the influence of perazine therapy (author's transl)]. Petruch F, Schüppel R, Breyer U. Arzneimittelforschung; 1976 Nov; 26(6):1154-5. PubMed ID: 9113 [Abstract] [Full Text] [Related]
10. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia]. Termińska K, Mrowiec W. Psychiatr Pol; 1989 Nov; 23(1):24-30. PubMed ID: 2573098 [Abstract] [Full Text] [Related]
13. [Specific binding of perazine, a piperazine side-chain phenothiazine drug, to a serum protein (author's transl)]. Schley J, Nündel M, Riedel E, Müller-Oerlinghausen B. Arzneimittelforschung; 1979 Nov; 29(1):106-8. PubMed ID: 36101 [Abstract] [Full Text] [Related]
14. [A differential effect profile of neuroleptic therapy of acute schizophrenic patients? Results of a clinico-naturalistic study]. Schmidt LG, Siemetzki H. Nervenarzt; 1988 Dec; 59(12):721-6. PubMed ID: 2905770 [No Abstract] [Full Text] [Related]
16. The outpatient clinic for patients under chronic lithium or neuroleptic treatment as a phase-IV research tool. Pietzcker A, Müller-Oerlinghausen B. Pharmacopsychiatry; 1984 Sep; 17(5):162-7. PubMed ID: 6149570 [Abstract] [Full Text] [Related]
18. Residual symptoms and P300 in schizophrenic outpatients. Juckel G, Müller-Schubert A, Gaebel W, Hegerl U. Psychiatry Res; 1996 Nov 01; 65(1):23-32. PubMed ID: 8953658 [Abstract] [Full Text] [Related]
19. Monitoring of serum bioactivity levels of perazine and its metabolites by radioreceptor assay. Rao ML. Pharmacopsychiatry; 1989 May 01; 22(3):104-7. PubMed ID: 2568642 [Abstract] [Full Text] [Related]
20. [Perazine-induced agranulocytosis--case report]. Möllering M. Z Kinder Jugendpsychiatr; 1988 Mar 01; 16(1):27-30. PubMed ID: 2898846 [Abstract] [Full Text] [Related] Page: [Next] [New Search]